RNA drug developer Sarepta Therapeutics disclosed that its CSO, Art Krieg, has been terminated from his position at the company.
Details about the termination were not made public.
Krieg most recently served as CEO of Rana Therapeutics, a startup focused on long non-coding RNA-based medicines. Before that, he led Pfizer's oligonucleotide therapeutics unit.